75 related articles for article (PubMed ID: 38536615)
1. Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan.
Mathijssen RH; Loos WJ; Verweij J; Sparreboom A
Curr Cancer Drug Targets; 2002 Jun; 2(2):103-23. PubMed ID: 12188913
[TBL] [Abstract][Full Text] [Related]
2. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform.
Saraf S; Jain A; Hurkat P; Jain SK
Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850).
Kimura T; Okada K; Morohashi Y; Kato Y; Mori M; Kato H; Matsumoto T; Shimoyama S
Pharm Res; 2024 Apr; 41(4):795-806. PubMed ID: 38536615
[TBL] [Abstract][Full Text] [Related]
4. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
5. Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: stability, pharmacokinetic and therapeutic evaluation.
Liu JJ; Hong RL; Cheng WF; Hong K; Chang FH; Tseng YL
Anticancer Drugs; 2002 Aug; 13(7):709-17. PubMed ID: 12187327
[TBL] [Abstract][Full Text] [Related]
6. Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.
Patankar NA; Waterhouse D; Strutt D; Anantha M; Bally MB
Invest New Drugs; 2013 Feb; 31(1):46-58. PubMed ID: 22615060
[TBL] [Abstract][Full Text] [Related]
7. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.
Zucker D; Barenholz Y
J Control Release; 2010 Sep; 146(3):326-33. PubMed ID: 20685223
[TBL] [Abstract][Full Text] [Related]
8. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.
Matsumoto T; Komori T; Yoshino Y; Ioroi T; Kitahashi T; Kitahara H; Ono K; Higuchi T; Sakabe M; Kori H; Kano M; Hori R; Kato Y; Hagiwara S
Pharm Res; 2021 Jun; 38(6):1093-1106. PubMed ID: 33961188
[TBL] [Abstract][Full Text] [Related]
9. FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor Microenvironment.
Shimoyama S; Okada K; Kimura T; Morohashi Y; Nakayama S; Kemmochi S; Makita-Suzuki K; Matulonis UA; Mori M
Mol Cancer Ther; 2023 Dec; 22(12):1454-1464. PubMed ID: 37683276
[TBL] [Abstract][Full Text] [Related]
10. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin.
Aloss K; Hamar P
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986754
[TBL] [Abstract][Full Text] [Related]
11. Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review.
Bai X; Smith ZL; Wang Y; Butterworth S; Tirella A
Micromachines (Basel); 2022 Sep; 13(10):. PubMed ID: 36295976
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment.
Subhan MA; Yalamarty SSK; Filipczak N; Parveen F; Torchilin VP
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207137
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs.
He H; Yuan D; Wu Y; Cao Y
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30866479
[TBL] [Abstract][Full Text] [Related]
14. The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.
Smits EAW; Soetekouw JA; Pieters EHE; Smits CJP; de Wijs-Rot N; Vromans H
Invest New Drugs; 2019 Oct; 37(5):890-901. PubMed ID: 30547315
[TBL] [Abstract][Full Text] [Related]
15. Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.
Schorzman AN; Lucas AT; Kagel JR; Zamboni WC
Methods Mol Biol; 2018; 1831():201-228. PubMed ID: 30051434
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
